Agenzia Italiana del Farmaco
Home
Press Release n. 643 - The Italian Medicines Agency has published the third COVID-19 Vaccine Surveillance Report.
Press release no. 642 - AIFA has recently recorded a worrying increase in reports received from citizens, associations and companies, of products purchased online from unauthorised channels, which have been found to be falsified or illegal, and draws attention to the risks associated with this type of purchase.
Press release no. 641 - The data analysis was competed of the randomised and controlled clinical trial called TSUNAMI, promoted by the ISS and AIFA and coordinated by the ISS, on the therapeutic role of convalescent plasma in patients who have developed the COVID-19 disease.
Giovedì 15 aprile secondo seminario scientifico dal titolo “Causalità e casualità nei recenti segnali di farmacovigilanza dei vaccini Covid-19: quali evidenze per le decisioni di salute pubblica?”
Medicines alerts
AIFA Focus
"Do you want to know more about COVID-19 vaccines?"
15 April
13:30
15 April
09:00 - 19:00
16 April
14:00 - 16:00
Consult the list of insolvency procedures for the recruitment of personnel.
Competitions
Go to the section that collects information on purchasing procedures.